AChE-HDAC-IN-1

Displayed potent and selective inhibition of HDAC, AChE and BuChE enzymes at subnanomolar range with IC50 of 0.23, 0.12 and 361.52 nM, towards HDAC, AChE and BuChE, respectively and showed inhibitory activity on Abeta42 self-aggregation and disaggregation activity on pre-formed Abeta fibrils. Has antioxidant activity. It is an inhibitor of isoforms of HDAC with IC50 values of 74.22, 134.7, 31.63 and 33.42 nM, against HDAC1, HDAC2, HDAC3 and HDAC6, respectively

General

Type : Multitarget, HDAC inhibitor, Derivative of Tacrine, anti-Abeta-aggregation, Antioxidant

Chemical_Nomenclature : N-[3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl]-4-[(E)-3-(hydroxyamino)-3-oxoprop-1-enyl]benzamide

Canonical SMILES : C1CCC2=NC3=C(C=CC(=C3)Cl)C(=C2C1)NCCCNC(=O)C4=CC=C(C=C4)\/C=C\/C(=O)NO

InChI : InChI=1S\/C26H27ClN4O3\/c27-19-11-12-21-23(16-19)30-22-5-2-1-4-20(22)25(21)28-14-3-15-29-26(33)18-9-6-17(7-10-18)8-13-24(32)31-34\/h6-13,16,34H,1-5,14-15H2,(H,28,30)(H,29,33)(H,31,32)\/b13-8+

InChIKey : WNEPUZILCBHSEU-MDWZMJQESA-N

Other name(s) : HY-147962  ||  CS-0530460


MW : 479

Formula : C26H27ClN4O3

CAS_number : 2414053-06-6

PubChem : 155666154

UniChem : WNEPUZILCBHSEU-MDWZMJQESA-N

Target

Families : AChE-HDAC-IN-1 ligand of proteins in family
ACHE BCHE

Protein :
human-ACHE human-BCHE

References (1)

Title : Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation - Xu_2020_Bioorg.Chem_98_103721
Author(s) : Xu A , He F , Zhang X , Li X , Ran Y , Wei C , James Chou C , Zhang R , Wu J
Ref : Bioorg Chem , 98 :103721 , 2020
Abstract :
PubMedSearch : Xu_2020_Bioorg.Chem_98_103721
PubMedID: 32193030